Psilocybin Legal Status: All 50 States Compared

Psilocybin, a naturally occurring psychedelic compound found in certain species of mushrooms, has been a focus of scientific research for its potential therapeutic benefits, particularly in treating depression, anxiety, PTSD, and addiction. However, its legal status varies significantly across the parasols states mushrooms are legal in United States, creating a complex landscape for users, researchers, and policymakers. This article provides a detailed overview of the legal status of psilocybin in all 50 states, highlighting current regulations, decriminalization efforts, and emerging trends.

Federal Overview

At the federal level, psilocybin is classified as a Schedule I controlled substance under the Controlled Substances Act. This classification means it is illegal to manufacture, possess, or distribute psilocybin for recreational use. Schedule I substances are defined as having a high potential for abuse, no currently accepted medical use, and a lack of accepted safety for use under medical supervision. Despite federal restrictions, several states and local jurisdictions have started to challenge this status through decriminalization or regulated therapeutic use programs.

States Where Psilocybin is Legal or Decriminalized

Oregon

Oregon is the first state to legalize psilocybin for therapeutic use through the Oregon Psilocybin Services Act, passed in 2020. Adults 21 and older can access psilocybin in supervised, licensed therapy sessions. The state also allows the cultivation of psilocybin-producing mushrooms for these sessions, but recreational use outside licensed facilities remains illegal.

Colorado

In 2022, Colorado voters passed Proposition 122, which decriminalized personal use and possession of psilocybin and psilocin for adults 21 and over. The measure also created a framework for licensed healing centers to provide psilocybin-assisted therapy, though the commercial market is still being developed.

Washington, D.C.

While not a state, Washington, D.C. voters approved Initiative 81 in 2020, which effectively decriminalizes the possession and cultivation of psilocybin and other entheogenic plants. Law enforcement is instructed to make psilocybin possession the lowest priority for prosecution.

Other Decriminalized Jurisdictions

Several cities and counties in the U.S. have decriminalized psilocybin even if the state law remains restrictive. These include Denver, Colorado; Oakland and Santa Cruz, California; Ann Arbor, Michigan; and Seattle, Washington. In these jurisdictions, law enforcement deprioritizes the enforcement of psilocybin possession laws, often resulting in minimal or no legal consequences for adults possessing small amounts.

State-by-State Breakdown

Alabama

Psilocybin is illegal in Alabama, classified as a Schedule I controlled substance. Possession, sale, or manufacture can result in severe criminal penalties, including prison time and fines.

Alaska

Psilocybin is illegal in Alaska under state law. Possession and distribution are criminal offenses, although there is growing advocacy for decriminalization.

Arizona

Psilocybin remains illegal, but the state allows research with psilocybin under tightly controlled conditions. Personal use or distribution is prohibited.

Arkansas

Psilocybin is classified as a Schedule I substance and is illegal for all purposes. The state has not yet initiated any decriminalization or therapeutic programs.

California

Psilocybin is illegal under state law; however, certain cities like Oakland, Santa Cruz, and San Francisco have decriminalized its possession. The statewide movement for therapeutic access is gaining momentum but has not yet passed legislation.

Colorado

Psilocybin is decriminalized and legal for regulated therapeutic use. Adults 21 and older can participate in supervised sessions at licensed centers.

Connecticut

Psilocybin is illegal in Connecticut. Possession and distribution carry criminal penalties, though recent discussions in the state legislature have considered potential medical studies.

Delaware

Psilocybin is classified as a Schedule I substance, making possession, sale, and cultivation illegal.

Florida

Psilocybin remains illegal and classified as a Schedule I controlled substance. The state has no decriminalization programs, though limited clinical research is allowed under strict regulatory conditions.

Georgia

Psilocybin is illegal in Georgia, with criminal penalties for possession and distribution. Advocacy groups are active but legislation has not advanced significantly.

Hawaii

Psilocybin is illegal, though research into psychedelic-assisted therapies is permitted under federal and state oversight.

Idaho

Psilocybin is illegal, and the state has strict penalties for possession, distribution, or cultivation.

Illinois

Psilocybin is illegal statewide, but advocacy efforts are increasing, focusing on potential medical legalization programs.

Indiana

Psilocybin is illegal under state law, with criminal penalties for possession, sale, and manufacture.

Iowa

Psilocybin is illegal, with Schedule I classification. No decriminalization or therapeutic programs exist.

Kansas

Psilocybin is illegal, with criminal penalties for possession, sale, or manufacture. Limited research under federal exemption is possible.

Kentucky

Psilocybin is illegal, classified as a Schedule I substance. No decriminalization initiatives are in place.

Louisiana

Psilocybin is illegal, but the state allows limited research under controlled conditions.

Maine

Psilocybin is illegal, although several municipalities are exploring decriminalization measures.

Maryland

Psilocybin is illegal, but the state is considering therapeutic access programs through legislative proposals.

Massachusetts

Psilocybin is illegal, but some cities, like Somerville and Cambridge, have decriminalized its possession.

Michigan

Psilocybin is illegal statewide, but Ann Arbor has decriminalized its personal use and possession.

Minnesota

Psilocybin remains illegal, though research programs are permitted in collaboration with federally approved institutions.

Mississippi

Psilocybin is illegal under state law, with severe penalties for possession, sale, and distribution.

Missouri

Psilocybin is illegal, and no decriminalization efforts have been implemented at the municipal level.

Montana

Psilocybin is illegal, although limited research is allowed under federal exemptions.

Nebraska

Psilocybin is illegal, with no current decriminalization programs or therapeutic frameworks.

Nevada

Psilocybin is illegal statewide, though Las Vegas and Reno have seen discussions about decriminalization and medical access.

New Hampshire

Psilocybin is illegal but under consideration for clinical research and therapeutic trials.

New Jersey

Psilocybin is illegal, but there is growing support for medical research and potential future legalization programs.

New Mexico

Psilocybin remains illegal, although some therapeutic research has been permitted under federal and state guidelines.

New York

Psilocybin is illegal, but advocacy groups are actively pursuing decriminalization in major cities, including New York City.

North Carolina

Psilocybin is illegal with strict penalties for possession, sale, and cultivation.

North Dakota

Psilocybin is illegal and classified as a Schedule I controlled substance.

Ohio

Psilocybin is illegal, but research is allowed under specific conditions approved by regulatory authorities.

Oklahoma

Psilocybin is illegal, with no decriminalization or therapeutic programs currently in place.

Oregon

Psilocybin is legal for supervised therapeutic use and regulated under state law for licensed adults.

Pennsylvania

Psilocybin is illegal, although medical research is permitted under federal and state oversight.

Rhode Island

Psilocybin is illegal, but local advocacy for therapeutic programs is increasing.

South Carolina

Psilocybin is illegal, with strict penalties for possession and distribution.

South Dakota

Psilocybin is illegal, though limited research may be conducted under state and federal supervision.

Tennessee

Psilocybin is illegal and classified as a Schedule I substance.

Texas

Psilocybin is illegal, with no statewide decriminalization programs, though advocacy for medical research continues.

Utah

Psilocybin is illegal, but therapeutic research is permitted in controlled settings.

Vermont

Psilocybin is illegal, though decriminalization is being discussed at the municipal level.

Virginia

Psilocybin is illegal, but limited research programs are allowed for medical studies.

Washington

Psilocybin is illegal statewide, but several cities, including Seattle, have decriminalized personal use. Statewide legalization efforts for therapy are ongoing.

West Virginia

Psilocybin is illegal with no current decriminalization or therapeutic programs.

Wisconsin

Psilocybin is illegal, but advocacy for medical and therapeutic use is increasing.

Wyoming

Psilocybin is illegal, with Schedule I classification and strict penalties for violations.

Emerging Trends

The legal landscape of psilocybin is shifting rapidly. Several states are considering regulated therapeutic programs, while municipalities increasingly adopt decriminalization policies. Public opinion is gradually moving toward acceptance of psilocybin for mental health purposes, and research demonstrating its efficacy and safety is influencing policymakers. It is likely that the coming years will see more states either decriminalizing psilocybin or creating controlled access programs similar to Oregon and Colorado.

Conclusion

Psilocybin remains federally illegal in the United States, but state-level policies are evolving quickly. Oregon and Colorado are leading the way with regulated therapeutic programs, while cities like Denver, Oakland, and Ann Arbor have decriminalized personal use. Most other states still maintain strict prohibitions, though advocacy for medical and therapeutic access continues to grow. As scientific evidence of psilocybin’s benefits accumulates, the legal landscape will likely continue to evolve, potentially paving the way for broader acceptance and regulated use across the nation.